Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01744691 |
|---|---|
| Brief Title: | A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion |
| First Submitted : | December 3, 2012 |
| First Submitted that Met QC Criteria : | December 6, 2012 |
| First Posted : | December 7, 2012 (Estimate) |
| Results First Submitted : | May 21, 2015 |
| Results First Submitted that Met QC Criteria : | May 21, 2015 |
| Results First Posted : | June 9, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 9, 2017 |
| Last Update Posted : | February 27, 2017 |